Primary |
Drug Use For Unknown Indication |
22.2% |
Hypocalcaemia |
22.2% |
Diuretic Therapy |
11.1% |
Gastric Ulcer |
11.1% |
Lung Disorder |
11.1% |
Pain |
11.1% |
Urinary Tract Infection |
11.1% |
|
Pancytopenia |
50.0% |
Vomiting |
50.0% |
|
Secondary |
Product Used For Unknown Indication |
37.3% |
Drug Use For Unknown Indication |
25.9% |
Haemolytic Uraemic Syndrome |
10.4% |
Hypertension |
5.2% |
Dialysis |
3.1% |
Rheumatoid Arthritis |
3.1% |
Diabetes Mellitus |
2.1% |
Arrhythmia Supraventricular |
1.6% |
Palpitations |
1.6% |
Atrial Fibrillation |
1.0% |
Diuretic Therapy |
1.0% |
Gastric Ulcer |
1.0% |
Hyperphosphataemia |
1.0% |
Hypocalcaemia |
1.0% |
Immunisation |
1.0% |
Pain |
1.0% |
Polyuria |
1.0% |
Essential Hypertension |
0.5% |
Peritoneal Dialysis |
0.5% |
Renal Failure Chronic |
0.5% |
|
Rash Erythematous |
14.8% |
Thrombocytopenia |
14.8% |
Cardio-respiratory Arrest |
11.1% |
Hypertension |
7.4% |
Melanosis Coli |
7.4% |
Pancytopenia |
7.4% |
Drug Interaction |
3.7% |
Eosinophilia |
3.7% |
Hypoglycaemia |
3.7% |
Hypoxic-ischaemic Encephalopathy |
3.7% |
Jaundice |
3.7% |
Sepsis |
3.7% |
Splenomegaly |
3.7% |
Tooth Infection |
3.7% |
Toxic Skin Eruption |
3.7% |
Vomiting |
3.7% |
|
Concomitant |
Drug Use For Unknown Indication |
39.3% |
Product Used For Unknown Indication |
19.0% |
Renal Transplant |
9.9% |
Multiple Myeloma |
3.8% |
Transplant Rejection |
3.6% |
Hypertension |
3.1% |
Peritoneal Dialysis |
2.8% |
Prophylaxis |
1.8% |
Tuberculosis |
1.8% |
Coronary Arterial Stent Insertion |
1.7% |
Peritonitis Sclerosing |
1.7% |
Hepatitis C |
1.5% |
Prophylaxis Against Transplant Rejection |
1.5% |
Dialysis |
1.3% |
Renal Failure |
1.3% |
Rheumatoid Arthritis |
1.3% |
Anaemia |
1.2% |
Diabetes Mellitus |
1.2% |
Pain |
1.2% |
Glomerulonephritis |
1.0% |
|
Aplastic Anaemia |
10.5% |
Toxic Skin Eruption |
9.3% |
International Normalised Ratio Increased |
8.1% |
Renal Failure Acute |
7.0% |
Cholestasis |
5.8% |
Malaise |
5.8% |
Tachycardia |
5.8% |
Wound Dehiscence |
5.8% |
Peritonitis Sclerosing |
4.7% |
Pyrexia |
4.7% |
Vomiting |
4.7% |
Lung Disorder |
3.5% |
Peritoneal Cloudy Effluent |
3.5% |
Pulmonary Embolism |
3.5% |
Respiratory Distress |
3.5% |
Somnolence |
3.5% |
Thrombocytopenia |
3.5% |
Anaphylactic Shock |
2.3% |
Anastomotic Haemorrhage |
2.3% |
Cardiac Arrest |
2.3% |
|